Document RpM453YrwXj0Vn9EoxB4an0ZE

EASE 2023-2038 - Document Register Title of document Type of document ARES number 1 CSS discussion - Eurometaux/DG GROW 2020-12-18 2 Essential use and RM route identification Guidance to the Template Framework to 3 Self-Reflect and Assess the main impacts of the CSS measure Template Framework to Self-Reflect and 4 Assess the main impacts of the CSS measure 5 Minutes meeting SMEunited-DG GROW of 2021-04-22 6 Quick feedback from Eurometaux Regulatory Forum 7 Minutes meeting with Essential Use coalition of 2021-06-04 Exchange of emails Document Eurometaux Document Eurometaux Document Eurometaux Document Document Document Ares(2023)3052284 Ares(2023)3052284 Ares(2023)3052284 Ares(2023)3052284 Ares(2021)2732921 Ares(2021)2707534 Ares(2021)5927340 8 Essential Use concept Document Ares(2021)5927340 9 Minutes meeting with 3M of 2021-06-15 Document Ares(2021)4051747 10 Meeting with EC DG GROW Document 3M Ares(2021)4051747 11 Minutes meeting COCIR of 2021-06-17 Document 12 Medical Devices: EU Investments in R&D Challenges and opportunities Document COCIR COCIR - Follow up to the meeting on 17 13 June - Documentation on RoHS - 2021-06- 22 Exchange of emails 14 Horizon scanning meeting: 16 June according to Doodle - 2021-06-23 Exchange of emails CEFICCOM Cefic welcomes the move towards "One 15 Substance-One Assessment" and supports close collaboration between EU agencies and scientific bodies 16 Cefic calls upon robust evidence and coherence when grouping substances Document CEFIC Document CEFIC 17 How to introduce the 'Essential Uses' Concept under REACH Document CEFIC 18 Slides Webinar on CSS - 2021-07-08 Email FIPRA Ares(2021)3991966 Ares(2021)3991966 Ares(2023)3052284 Ares(2023)3052284 Ares(2023)3052284 Ares(2023)3052284 Ares(2023)3052284 Ares(2023)3052284 Attachment(s) Disclosure? (Y/N) Exception Y (see docs 2-3-4) Y Y Art.4(1)b Y Y Y Y Y (see doc 8) Y Y Y (see doc 10) Y Y Y (see doc 12) Y Y Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Y Art.4(1)b Y (see docs 15-16-17) Y Art.4(1)b N Y Y Y (see docs 19-20) Y Art.4(1)b Art.4(1)b Art.4(1)b Comments Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Out of scope Ref. Ares(2023)4039882 - 12/06/2023 EASE 2023-2038 - Document Register CSS and the impact on industry - Part 1 19 Grouping of chemicals and generic risk Document kopol Ares(2023)3052284 Y assessment - potential practical implications CSS and the impact on Industry - Part 2 20 Substances of concern - results from Document kopol Ares(2023)3052284 N screening study on upcoming challenges for the Medtech Industry Meeting report Cobalt Institute-GROW unit 21 F1 meeting on essential use concept of Document Ares(2021)5900322 Y 2021-09-27 22 Outcome meeting with Lanxess on Document Ares(2021)6229884 Y Essential Uses of 2021-10-12 23 Minutes meeting with AmCham on Document Ares(2021)6245853 Y essential uses of 2021-10-13 24 Meeting request from UEIL on the Exchange of emails COM- Ares(2023)3052284 Y (see doc 25) Y Chemicals Strategy - 2021-10-15 UEIL 25 HSE committee meeting with DG GROW - Document UEIL Ares(2023)3052284 Y Online meeting - 15 October 2021 26 ATC Meeting materials Nov 4th 2021 Essential Uses - 2021-10-29 Email ATC Ares(2023)3052284 Y (see docs 27-28-29- Y 30) 27 Introduction to ATC Document ATC Ares(2023)3052284 Y 28 Fuel Additives - Use and Benefits Document ATC Ares(2023)3052284 Y 29 Lubricant Additives - Use and Benefits Document ATC Ares(2023)3052284 Y 30 Industrial Lubricants: Applications and Document ATC Ares(2023)3052284 Y Impact of Additives on Performance 31 Minutes - Meeting MedTech Europe on Document Ares(2021)7199877 Y ESU of 2021-11-19 32 Minutes Business Europe Environment Document Ares(2023)3052284 Y Workign Group 33 Launch of Economic Analysis of the Emails CEFIC Ares(2023)3052284 Y (see doc 34) Y Impacts of the CSS - Phase 1 - 2021-12-02 Economic Analysis of the Impacts of the 34 Chemicals Strategy for Sustainability - Document CEFIC Ares(2023)3052284 Y Phase 1 report 35 Essential Uses - Follow up from EFPIA - Email EFPIA Ares(2023)3052284 Y 2021-12-17 36 Minutes meeting with CEFIC of 2021-12-20 Document Ares(2021)7899233 Y Art.4(1)b Out of scope Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Redaction of personal data and of parts out of scope EASE 2023-2038 - Document Register 37 Minutes meeting with ASD - 2022-01-16 Document Ares(2023)3052284 Y 38 Minutes meeting with ACEA of 2022-01-20 Document Ares(2022)488971 Y 39 Minutes meeting with Chemours on ESU of Document Ares(2022)747805 Y 2022-02-01 40 Minutes meeting with AnimalhealthEurope Document Ares(2022)941057 Y on PFAS and Essential Uses of 2022-02-07 41 Minutes meeting with EPEE on U-PFAS Document Ares(2022)1065748 Y and Essential Uses of 2022-02-11 42 Minutes AmCham event of 2022-02-24 Document Ares(2023)3052284 Y 43 Minutes meeting with CEFIC of 2022-02-25 Document Ares(2022)1508631 Y 44 JBCE Environment Committee meeting on Exchange of emails COM- Ares(2023)31302226 Y (see doc 45) Y 2nd March 14:00-15:00 - 2022-02-28 JBCE 45 EU Chemicals Strategy for Sustainability - Document Ares(2023)31302226 Y Essential Uses 46 Minutes meeting with the International Document Ares(2022)181738 Y Bromine Council (BSEF) - 2022-03-10 47 Minutes meeting with German Fashion - Document Ares(2023)3052284 Y 2022-03-10 48 REACH-OSH Forum - Draft Agenda - 2022- Exchange of emails COM- Ares(2023)3052284 Y (see doc 49) Y 04-01 Hanovercomms EU Chemicals Strategy for Sustainability 49 REACH and Occupational Safety and Document Ares(2023)3052284 Y Health - Perspectives for the planned REACH revision 50 Minutes meeting with ASMoR - 2022-04-06 Document Ares(2022)2662430 Y 51 Minutes meeting with BusinessEurope - Document Ares(2022)3796065 Y 2022-05-13 Extension of the generic approach to risk Exchange of emails COM- 52 management - engagement with AISE Ares(2023)3052284 Y (see docs 53-54) Y formulators/DUCC - 2022-05-13 53 Extension of the GRA to professionals - Document FEICA Ares(2023)3052284 Y FEICA exemples - 13 May 2022 54 Extension of the GRA - AMFEP & AISE Document DUCC-AMFEP- Ares(2023)3052284 Y example - 13 May 2022 AISE 55 Minutes meeting AISE-Cosmetics Europe- Document Ares(2022)3689667 Y IFRA - 2022-05-16 56 Minutes meeting with COCIR - 2022-05-18 Document Ares(2022)3796819 Y 57 Minutes workshop by DUCC of 2022-05-19 Document Ares(2023)3052284 Y (see doc 58) Y 58 DUCC Use & Exposure Survey - RPA Document DUCC Ares(2023)3052284 Y presentation - 19th May 2022 59 Minutes meeting with Fuels Europe - 2022- Document Ares(2022)4225465 Y 06-07 Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Art.4(2) Art.4(1)b Art.4(1)b Art.4(1)b Redaction of commercial data Art.4(1)b EASE 2023-2038 - Document Register 60 Minutes meeting with CEPE - 2022-06-10 Document 61 Minutes meeting with Novozymes - 202206-27 Document 62 Follow-up on meeting with Novozymes 2022-06-28 Exchange of emails COMNovozymes Minutes meeting with AMFEP-IFFNovozymes to discuss the impacts of the 63 application of the GRA on enzymes in consumer and professional products in various industries - 2022-07-07 64 Enzymes and Generic Risk Assesment (GRA) - July 7, 2022 Document Document AMFEP 65 Minutes meeting with EFPIA on REACH Revision - 2022-07-08 Document 66 Pharmaceutical Supply Chain - Current Applicability of REACH & CLP Document EFPIA Chemicals Strategy for Sustainability and 67 Medicinal Products: How the EU Chemicals Legislation Interlinks with the EU Pharmaceutical Sectoral Legislation Document EFPIA Ares(2022)4379862 Ares(2022)4985948 Ares(2022)4729186 Ares(2022)5758050 Ares(2022)5758050 Ares(2022)5348176 Ares(2022)5348176 Ares(2022)5348176 Y (see doc 64) Y (see docs 66-67) Y Art.4(1)b Y Art.4(1)b Redaction of personal data and of parts out of scope Y Art.4(1)b Redaction of personal data and of parts out of scope Y Art.4(1)b Y Art.4(1)b and Art.4(2) Redaction of personal data and of commercial data Y Art.4(1)b Y Y 68 Minutes meeting ASD - 2022-07-13 Document Ares(2022)516376 Y Art.4(1)b 69 Follow-up exchange on CSS Bayer / DG GROW 26 July - 2022-08-15 Email Bayer Ares(2022)5763983 Y (see docs 70-71-72) Y 70 Training obligations under the Sustainable Document CropLife Ares(2022)5763983 Y Use of Pesticides Directive CropLife Europe input on PMT/vPvM 71 criteria in response to CARACAL meeting Document CropLife Ares(2022)5763983 N (Ad-hoc CA/17/2021 rev.1) Impact assessment for Pesticide Active 72 Ingredients: New CLP Hazard Classes Document CropLife Ares(2022)5763983 N (PMT, vPvM) 8 September 2022 meeting with FEICA // 73 Proposal for a training on the safe use of Email FEICA Ares(2023)3052284 Y (see doc 74) Y the most harmful chemicals - 2022-09-07 Proposal for a training on the safe use of 74 the most harmful chemicals - An industry Document FEICA Ares(2023)3052284 Y committment 8 September 2022 Minutes meeting report FEICA-GROW unit 75 F1 meeting on proposal for a training on the safe use of the most harmful chemicals - 2022-09-08 Document Ares(2022)6241629 Y (see above doc 74) Y Minutes meeting with Beryllium Science 76 and Technology Association (BeST) - 2022- Document Ares(2022)6661285 Y 09-20 77 Follow-up meeting with Novozymes on 15 September 2022 - 2022-09-20 Email Novozymes Ares(2023)3052284 Y (see docs 78-79-80- Y 81-82) 78 Novozymes' contribution to the European Document Novozymes Ares(2023)3052284 Y Green Deal 79 Defining bio-based substances in EU Document Novozymes Ares(2023)3052284 Y regulation Art.4(1)b Redaction of personal data and of parts out of scope Art.4(1)b Out of scope Out of scope Art.4(1)b Art.4(1)b Art.4(1)b EASE 2023-2038 - Document Register 80 The EU Taxonomy Risks Undemining the Document Novozymes Ares(2023)3052284 N Green Deal Goals for Bio-Based products The potentials of bio solutions - Climate Copenhagen Economics 81 and sustainability, barriers to growth, and (CE) Document Ares(2023)3052284 N Danish strongholds 82 The Safety of Industrial Enzymes Document Novozymes Ares(2023)3052284 N 83 Minutes meeting with L'Oral on REACH Document Ares(2022)6524040 Y revision - 2022-09-21 84 Minutes meeting with Eurometaux - 2022- Document Ares(2023)3052284 Y 10-11 85 BeST meeting 20 September - Follow-up - Email BeST Ares(2022)7178336 Y (see doc 86) Y 2022-10-17 86 Overview of BeST's positions - 2022-10-17 Document BeST Ares(2022)7178336 Y 87 DUCC priorities on the REACH and CLP Exchange of emails COM- Ares(2022)7385362 Y (see doc 88-89) Y revisions - 2022-10-24 AISE 88 Downstream users - 10 priorities for the Document DUCC Ares(2022)7385362 Y REACH Revision 89 Downstream users - 8 priorities for the CLP Document DUCC Ares(2022)7385362 N Revision 90 Minutes meeting with CEFIC - 24 Document Ares(2022)8445741 Y November 2022, 11-12 91 Meeting with BASF - Follow-up of visit of Emails BASF Ares(2023)3052284 Y (see doc 92) Y 28 June - 2022-11-25 92 CSS - Our proposal to reach CSS Document BASF Ares(2023)3052284 Y objectives while remaining competitive 93 Minutes ASMoR meeting - 2022-11-28 Document Ares(2022)8331894 Y (see doc 94) Y 94 The Alliance for Sustainable Management Document ASMoR- Ares(2022)8331894 Y of Chemical Risk Hanovercomms 95 Minutes meeting with Sherwin-Willimas - Document Ares(2022)8684187 Y 2022-12-06 96 Thank you note Sherwin Williams - 2022- Email Sherwin Ares(2022)8800105 Y (see doc 97) Y 12-15 Rethinking chemicals: An overview of key 97 principles that should guide the revision of Sherwin-Williams document Ares(2022)8800105 N chemical regulations 98 Minutes meeting Commission - CEFIC - Document Ares(2023)3076250 Y GRA & Essential Uses - 19 January 2023 99 Minutes meeting with EFPIA - 2023-01-23 Document Ares(2023)970990 Y 100 REACH/Raw materials 13022023 - 2023- Email Eurometaux Ares(2023)3052284 Y (see doc 101) Y 02-14 Discussion with DG GROW on the 101 coherence Raw materials-REACH and Document Eurometaux Ares(2023)3052284 Y (see docs 102-103) Y REACH - 13 February 2023 - Draft notes Eurometaux Europe's raw materials investment push: 102 Making EU chemicals policy an enabler not Document Eurometaux Y a barrier Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Out of scope Out of scope Out of scope Redaction of personal data and of parts out of scope Art.4(1)b Art.4(1)b Out of scope Redaction of personal data and of parts out of scope Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Out of scope Redaction of personal data and of parts out of scope Key topics for REACH 2,0 drafting and 103 related policy discussions including the CRM Act 104 Question on Essential Use Concept FIPRA - 2023-03-03 105 Minutes meeting with CEPE - 2023-03-08 Notes meeting Kristin Schreiber with 106 Economy Minister of North-Rhine- Westphalia (NRW) 14.03.2023 - by videoconference 107 H&M Group's position on the revision of REACH Regulation - 2023-03-16 H&M Group's suggestions to secure an 108 ambitious revision of REACH Regulation - March 2023 109 Thank you for the meeting - 2023-03-16 Minutes of the meeting with Cefic, 110 SMEunited and SMEs on the REACH Revision - 2023-03-21 Minutes on the exchange with the 111 Confederation of the German Textile and Fashion Industry - 2023-03-22 Minutes on meeting with DUCC on second 112 DUCC workshop on Assessment of Alternative Substances in Mixtures - 202304-11 Document Eurometaux Exchange emails COM- FIPRA Document Document Emails H&M Document H&M Email AMFEP Document Document Document Ares(2023)3169915 Ares(2023)2622921 Ares(2023)2071194 Ares(2023)2732684 Ares(2023)2732684 Ares(2023)3052284 Ares(2023)2392214 Ares(2023)2223073 Ares(2023)2613968 EASE 2023-2038 - Document Register Y Y Y Y Y (see doc 108) Y Y Y Y Y Y Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Art.4(1)b Redaction of personal data and of parts out of scope Redaction of personal data and of parts out of scope Art.4(1)b